Increasing FLT3-ITD length increases expression of bcl-xl in AML.

被引:0
|
作者
Seedhouse, Claire H. [1 ]
Pallis, Monica [1 ]
Grundy, Martin [1 ]
Russell, Nigel [1 ]
机构
[1] Univ Nottingham Hosp, City Hosp Campus, Clin Sci Building, Nottingham NG7 2UH, England
关键词
D O I
10.1182/blood.V108.11.1909.1909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1909
引用
收藏
页码:541A / 541A
页数:1
相关论文
共 50 条
  • [11] FLT3-ITD Allelic Ratio and Length Predict Overall Survival in Childhood AML
    Cucchi, D.
    de Haas, V.
    Denys, B.
    Vandepoele, K.
    Philippe, J.
    Zweegman, S.
    Kaspers, G. J.
    Ossenkoppele, G.
    Schuurhuis, G. J.
    Cloos, J.
    Sonneveld, E.
    ANNALS OF HEMATOLOGY, 2017, 96 : S77 - S77
  • [12] Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
    Tamara Castaño-Bonilla
    Juan M. Alonso-Dominguez
    Eva Barragán
    Rebeca Rodríguez-Veiga
    Claudia Sargas
    Cristina Gil
    Carmen Chillón
    María B. Vidriales
    Raimundo García
    Joaquín Martínez-López
    Rosa Ayala
    María J. Larrayoz
    Eduardo Anguita
    Rebeca Cuello
    Alberto Cantalapiedra
    Estrella Carrillo
    Elena Soria-Saldise
    Jorge Labrador
    Isabel Recio
    Lorenzo Algarra
    Carlos Rodríguez-Medina
    Cristina Bilbao-Syeiro
    Juan A. López-López
    Josefina Serrano
    Erik De Cabo
    María J. Sayas
    María T. Olave
    Joaquín Sánchez-García
    Mamen Mateos
    Carlos Blas
    Jose L. López-Lorenzo
    Daniel Lainez-Gonzalez
    Juana Serrano
    David Martínez-Cuadrón
    Miguel A. Sanz
    Pau Montesinos
    Scientific Reports, 11
  • [13] Dual activating FLT3-ITD/TKD mutations found in patients with AML induce resistance to FLT3 PTK inhibitors and daunorubicin by upregulation of Bcl-xL.
    Bagrintseva, K
    Geisenhof, S
    Schwab, R
    Eichenlaub, S
    Hiddemann, W
    Spiekermann, K
    BLOOD, 2003, 102 (11) : 590A - 590A
  • [14] STUDY OF THE LENGTH OF FLT3-ITD FRAGMENTS IN DIAGNOSED PATIENTS OF ACUTE MYELODE LEUKEMIA (AML)
    Castano Bonilla, T.
    Alonso Dominguez, J. M.
    Blas Lopez, C.
    Sanchez Rocio, Salgado N.
    Atance Pasarisas, M.
    Lopez, L. J. L.
    Ayala Diaz, R.
    Sillero Llamas, P.
    Lopez Martinez, J.
    HAEMATOLOGICA, 2018, 103 : 198 - 199
  • [15] Physiologic hypoxia of 6% O2 regulates FLT3-ITD expression and function in AML cell-lines harbouring a FLT3-ITD mutation
    Sironi, S.
    Wagner, M.
    Drolle, H.
    Vasold, J.
    Hiddemann, W.
    Fiegl, M.
    ONKOLOGIE, 2012, 35 : 117 - 118
  • [16] Detection of minimal residual disease in FLT3/ITD AML.
    Levis, Mark J.
    Miller, Jeffrey Edward
    Xie, Zhiyi
    McClain, Valerie
    Carson, Andrew R.
    Stenzel, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [17] FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML
    Jarno Kivioja
    Disha Malani
    Ashwini Kumar
    Mika Kontro
    Alun Parsons
    Olli Kallioniemi
    Caroline A. Heckman
    Scientific Reports, 11
  • [18] FLT3-ITD allelic ratio and HLF expression predict FLT3 inhibitor efficacy in adult AML
    Kivioja, Jarno
    Malani, Disha
    Kumar, Ashwini
    Kontro, Mika
    Parsons, Alun
    Kallioniemi, Olli
    Heckman, Caroline A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [19] FLT3-ITD Mutation in Relation to FLT3 Expression in Pediatric AML: A Prospective Study from India
    Sharawat, Surender Kumar
    Bakhshi, Radhika
    Vishnubhatla, Sreenivas
    Gupta, Ritu
    Bakhshi, Sameer
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2014, 31 (02) : 131 - 137
  • [20] Age-Dependent Frequencies of NPM-1/FLT3-ITD Mutations in Patients with Normal Karyotype AML.
    Schneider, Friederike
    Hoster, Eva
    Unterhalt, Michael
    Schneider, Stephanie
    Dufour, Annika
    Benthaus, Tobias
    Mellert, Gudrun
    Zellmeier, Evelyn
    Bohlander, Stefan K.
    Feuring-Buske, Michaela
    Buske, Christian
    Braess, Jan
    Heinecke, Achim
    Sauerland, Maria C.
    Berdel, Wolfgang E.
    Buechner, Thomas
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    BLOOD, 2008, 112 (11) : 879 - 879